Remote patient monitoring systems with integrated communication capabilities are set to number 9.4 million in 2017, up from just 2.8 million in 2012, according to new research from Berg Insight, while the number of devices with integrated cellular connectivity grows from 1.03 million in 2012 to 7.1 million in 2017.
“Widespread use of remote patient monitoring is still years away, but we are moving towards an age where mHealth solutions will become part of standard care pathways,” said Lars Kurkinen, a telecom analyst with Berg Insight. “Financial incentives are now coming into place and new mandates are formed that favorably affect the adoption of mHealth solutions. We believe 2013 will be a landmark year as the mHealth industry shifts into a strong growth phase that will last for many years to come.”
According to Berg Insight, the mHealth industry will receive a boost from several new developments this year. In the US, for instance, hospitals are being driven to adopt telehealth for monitoring post-discharge patients by the progressive increases to readmission penalties set by the Centers for Medicare & Medicaid Services (CMS).
In the UK, meanwhile, the National Health Service has issued a mandate for 100,000 additional patients to be monitored with telehealth solutions by March 2014, and in France a mandate on compliance monitoring will ensure that all new sleep therapy patients will be remotely monitored from 2013 onwards.
“Today cardiac rhythm management (CRM) is the most important segment of connected medical devices,” said Kurkinen. “However, we believe that connected sleep therapy devices will become the largest segment of connected medical devices by 2017, followed by the CRM and telehealth categories.”
“Connectivity is at the same time gaining momentum in several other segments such as blood pressure monitoring, glucose monitoring, ECG monitoring and medication adherence,” he added.